Stock Events

Stock Events

Search...

Ultragenyx Pharmaceutical (RARE) Q3 2025 Earnings

5AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-1.6

-1.46

-1.31

-1.17

Details

Expected EPS

-1.29719

Actual EPS

-1.17

Surprise EPS

0.13

Surprise Percent

+9.81%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -1.17 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.